Showing 771-780 of 2652 results for "".
The Future of Treating Diabetic Eye Disease?
https://modernod.com/topics/retina/eci-april-2023-video/37324/Joseph Allen, OD, FAAO, Dipl ABO, reviews everything you want to know about novel eye drop OTT166 (OcuTerra Therapeutics), which is in development for the treatment of diabetic retinopathy and diabetic macular edema, including its mechanism of action, pathway to the retina, and promising preliminaryNext Target: Dry AMD
https://modernod.com/articles/significant-findings/next-target-dry-amd/37730/Significant Findings is MOD's weekly email newsletter for progressive-minded, full scope optometrists. Delivered to your inbox every Monday, Significant Findings offers fresh insights on the latest industry news, life anecdotes, current events related to the practice of optometry, and more—all curat64. Get That Money Honey! Ft. Dr. Emilie Seitz
https://modernod.com/podcasts/four-eyes/64-get-that-money-honey-ft-dr-emilie-seitz/37014/Negotiating a contract as a new grad OD can be as terrifying as the first day of Optometry school. That’s why we’ve invited Dr. Emilie Seitz to the Four Eyes podcast to provide tips on negotiating contracts, identifying red flags, discussing money, and how to prioritize your needs. Dr. Seitz also shConjunctivochalasis
https://modernod.com/topics/ocular-surface/conjunctivochalasis/38586/“Loosen” your differential diagnosis when treating dry eye disease.Promising Safety Results With Investigational Dry Eye Drop
https://modernod.com/articles/significant-findings/promising-safety-results-with-investigational-dry-eye-drop/37726/Significant Findings is MOD's weekly email newsletter for progressive-minded, full scope optometrists. Delivered to your inbox every Monday, Significant Findings offers fresh insights on the latest industry news, life anecdotes, current events related to the practice of optometry, and more—all curatInvolving Patients in Their Care
https://modernod.com/articles/significant-findings/involving-patients-in-their-care/37725/Significant Findings is MOD's weekly email newsletter for progressive-minded, full scope optometrists. Delivered to your inbox every Monday, Significant Findings offers fresh insights on the latest industry news, life anecdotes, current events related to the practice of optometry, and more—all curatArtificial Tear Brand Linked to Eye Infections
https://modernod.com/articles/significant-findings/artificial-tear-brand-linked-to-eye-infections/37721/Significant Findings is MOD's weekly email newsletter for progressive-minded, full scope optometrists. Delivered to your inbox every Monday, Significant Findings offers fresh insights on the latest industry news, life anecdotes, current events related to the practice of optometry, and more—all curatA Renewed Appreciation for Refractions
https://modernod.com/articles/significant-findings/a-renewed-appreciation-for-refractions/37719/Significant Findings is MOD's weekly email newsletter for progressive-minded, full scope optometrists. Delivered to your inbox every Monday, Significant Findings offers fresh insights on the latest industry news, life anecdotes, current events related to the practice of optometry, and more—all curat61. Tidbits from New Grad ODs
https://modernod.com/podcasts/four-eyes/61-tidbits-from-new-grad-ods/37011/We’re back with another season of Four Eyes! Dr. Kar and Dr. Bilkhu kick off the season by sharing tidbits they’ve learned over the early years of their career in hopes to help new graduate optometrists find their confidence and know their worth. Some of the tidbits also stress important tips on refEBMD: Part 1
https://modernod.com/mod-issues/2022-nov-dec/ebmd-part-1/38536/This common corneal finding likes to hide in plain sight. Can you spot the signs?